Fight tumour with tumour (and T cells)
Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study,...
Read MoreLorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
Cutting cancer risk, no knife
The National Institute for Health and Clinical Excellence (NICE) has launched a consultation on an updated, draft version of their...
Read MoreThe clue is in the calcium
High levels of calcium in the blood stream might be indicative of ovarian cancer, according to a news study. Examination...
Read MoreThat Friday feeling – literally
A new initiative to encourage women to check themselves regularly for lumps has been launched by BE-gLOVE. This is a...
Read MoreMind your pills and IQs
New research shows that taking the antiepileptic drug valproate during pregnancy affects the IQ of children up to the age...
Read MoreInformation fit for pregnancy
Epilepsy Action say women suffering from epilepsy don’t receive the information about contraception, conception and pregnancy that they need. [caption...
Read MoreIndependent midwifery under threat
Independent Midwives UK fears that despite the Francis Report’s unveiling of the flaws and shortcomings of the NHS as a...
Read MoreUniversity lecturer shortlisted for Annual Midwifery Award
Dr Jayne Marshall, a lecturer at the University of Nottingham, has been nominated for a Royal College of Midwives (RCM)...
Read More
SUBSCRIBE TO OBS GYNAE & MIDWIFERY NEWS
and receive all of the latest news via our weekly newsletter
"*" indicates required fields